DIN 02539136 — NAT-ERIBULIN 0.5 MG
NAT-ERIBULIN is a solution of Eribulin marketed by NATCO PHARMA (CANADA) INC. The full Eribulin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02539136
- Brand name
- NAT-ERIBULIN
- Active ingredient
- Eribulin
- Strength
- 0.5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- NATCO PHARMA (CANADA) INC
- Health Canada status
- DORMANT
- Drug class
- Microtubule dynamics inhibitor (halichondrin B analog, antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Eribulin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02545950 | ERIBULIN MESYLATE INJECTION | 0.5 MG | SOLUTION | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02377438 | HALAVEN | 0.5 MG | SOLUTION | EISAI LIMITED | MARKETED |